| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100179 | Journal of Crohn's and Colitis | 2012 | 7 Pages |
Abstract
Once daily slow-release mesalazine is similarly effective to the standard twice daily schedule in patients with left-sided ulcerative colitis for the maintenance of remission in mild-to-moderate disease.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Bernd Bokemeyer, Daan Hommes, Ivo Gill, Per Broberg, Axel Dignass,